• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

100 years of the Bacillus Calmette-Guérin vaccine.

作者信息

Bettencourt Paulo J G, Joosten Simone A, Lindestam Arlehamn Cecilia S, Behr Marcel A, Locht Camille, Neyrolles Olivier

机构信息

Catholic University of Portugal, Lisbon, Portugal; Centre for Interdisciplinary Research in Health, Catholic University of Portugal, Lisbon, Portugal.

Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.

出版信息

Vaccine. 2021 Dec 8;39(50):7221-7222. doi: 10.1016/j.vaccine.2021.11.038. Epub 2021 Nov 22.

DOI:10.1016/j.vaccine.2021.11.038
PMID:34823911
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8638750/
Abstract
摘要

相似文献

1
100 years of the Bacillus Calmette-Guérin vaccine.卡介苗问世100周年。
Vaccine. 2021 Dec 8;39(50):7221-7222. doi: 10.1016/j.vaccine.2021.11.038. Epub 2021 Nov 22.
2
Predictive biomarkers of response to bacillus Calmette-Guérin immunotherapy and bacillus Calmette-Guérin failure for non-muscle invasive bladder cancer.预测卡介苗免疫治疗和卡介苗失败对非肌肉浸润性膀胱癌反应的生物标志物。
Int J Urol. 2022 Aug;29(8):807-815. doi: 10.1111/iju.14921. Epub 2022 May 22.
3
History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story.卡介苗与膀胱癌的历史：一个免疫治疗的成功故事。
J Urol. 2008 Jan;179(1):53-6. doi: 10.1016/j.juro.2007.08.122. Epub 2007 Nov 13.
4
Contributors to HMGB1 release by urothelial carcinoma cells in response to bacillus Calmette-Guérin.尿路上皮癌细胞对卡介苗反应导致高迁移率族蛋白 B1 的释放。
J Urol. 2013 Oct;190(4):1398-403. doi: 10.1016/j.juro.2013.03.123. Epub 2013 Apr 11.
5
Granulomas of the penis: a rare complication of intravesical therapy with Bacillus Calmette-Guerin.阴茎肉芽肿：卡介苗膀胱内灌注治疗的罕见并发症。
An Bras Dermatol. 2011 Jul-Aug;86(4):759-62. doi: 10.1590/s0365-05962011000400021.
6
Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guérin: Implications for Clinical Trial Design.卡介苗治疗非肌肉浸润性膀胱癌患者的当代结局：对临床试验设计的启示。
J Urol. 2021 Jun;205(6):1612-1621. doi: 10.1097/JU.0000000000001633. Epub 2021 Jan 27.
7
Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancer.非肌肉浸润性膀胱癌卡介苗维持治疗期间与治疗依从性相关的不良反应。
Jpn J Clin Oncol. 2013 Aug;43(8):827-34. doi: 10.1093/jjco/hyt086. Epub 2013 Jul 14.
8
Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer.卡介苗（BCG）：对抗病原体和癌症的武器。
Urol Oncol. 2021 Feb;39(2):121-129. doi: 10.1016/j.urolonc.2020.09.031. Epub 2020 Nov 28.
9
Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity.卡介苗疫苗与非特异性免疫。
Am J Med Sci. 2021 Jun;361(6):683-689. doi: 10.1016/j.amjms.2021.03.003. Epub 2021 Mar 8.
10
Efficacy of bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis.卡介苗菌株治疗非肌肉浸润性膀胱癌的疗效：系统评价和网络荟萃分析。
J Urol. 2017 Sep;198(3):503-510. doi: 10.1016/j.juro.2017.01.086. Epub 2017 Mar 10.

引用本文的文献

1
Integrative immune analysis in patients with leprosy reveals host factors associated with mycobacterial control.麻风病患者的综合免疫分析揭示了与分枝杆菌控制相关的宿主因素。
EBioMedicine. 2025 Jul 18;118:105855. doi: 10.1016/j.ebiom.2025.105855.
2
Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors.疫苗与痴呆：第一部分。BCG 增强非特异性免疫：历史、配体和受体。
J Alzheimers Dis. 2024;98(2):343-360. doi: 10.3233/JAD-231315.
3
Beyond schistosomiasis: unraveling co-infections and altered immunity.超越血吸虫病：揭示合并感染和免疫改变。
Clin Microbiol Rev. 2024 Mar 14;37(1):e0009823. doi: 10.1128/cmr.00098-23. Epub 2024 Feb 6.
4
BCG vaccination-induced acquired control of mycobacterial growth differs from growth control preexisting to BCG vaccination.BCG 疫苗接种诱导的分枝杆菌生长获得性控制与 BCG 疫苗接种前存在的生长控制不同。
Nat Commun. 2024 Jan 2;15(1):114. doi: 10.1038/s41467-023-44252-5.
5
mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV.mRNA 疫苗：疟疾、结核病和艾滋病的新机遇。
Front Immunol. 2023 Apr 24;14:1172691. doi: 10.3389/fimmu.2023.1172691. eCollection 2023.
6
Microbial Antigen Identification and Vaccine Delivery Systems.微生物抗原鉴定与疫苗递送系统
Vaccines (Basel). 2022 Nov 30;10(12):2053. doi: 10.3390/vaccines10122053.
7
Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c.评价结核分枝杆菌疫苗卡介苗和候选疫苗 BCGΔBCG1419c 对早期固有和适应性免疫应答的影响。
Sci Rep. 2022 Jul 20;12(1):12377. doi: 10.1038/s41598-022-14935-y.
8
Recombinant BCG to Enhance Its Immunomodulatory Activities.重组卡介苗以增强其免疫调节活性。
Vaccines (Basel). 2022 May 23;10(5):827. doi: 10.3390/vaccines10050827.
9
Is the BCG Vaccine an Answer to Future Pandemic Preparedness?卡介苗疫苗是应对未来大流行防范的答案吗？
Vaccines (Basel). 2022 Jan 27;10(2):201. doi: 10.3390/vaccines10020201.

本文引用的文献

1
BCG versus rBCG: What is the way forward?卡介苗与重组卡介苗：未来之路何在？
Vaccine. 2021 Dec 8;39(50):7319-7320. doi: 10.1016/j.vaccine.2021.10.052.
2
Donor Unrestricted T Cells: Linking innate and adaptive immunity.供者无限制 T 细胞：连接先天免疫和适应性免疫。
Vaccine. 2021 Dec 8;39(50):7295-7299. doi: 10.1016/j.vaccine.2021.10.044. Epub 2021 Nov 2.
3
BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease.麻风病患者家庭接触者中卡介苗诱导的免疫谱可区分保护作用和疾病情况。
Vaccine. 2021 Dec 8;39(50):7230-7237. doi: 10.1016/j.vaccine.2021.10.027. Epub 2021 Oct 20.
4
Effects of Mycobacterium bovis Calmette et Guérin (BCG) in oncotherapy: Bladder cancer and beyond.牛型分枝杆菌卡介苗（BCG）在肿瘤治疗中的作用：膀胱癌及其他。
Vaccine. 2021 Dec 8;39(50):7332-7340. doi: 10.1016/j.vaccine.2021.09.053. Epub 2021 Oct 7.
5
Weaker protection against tuberculosis in BCG-vaccinated male 129 S2 mice compared to females.与雌性相比，接种卡介苗的雄性129 S2小鼠对结核病的保护作用较弱。
Vaccine. 2021 Dec 8;39(50):7253-7264. doi: 10.1016/j.vaccine.2021.09.039. Epub 2021 Sep 30.
6
Recombinant BCGs for tuberculosis and bladder cancer.结核和膀胱癌的重组卡介苗。
Vaccine. 2021 Dec 8;39(50):7321-7331. doi: 10.1016/j.vaccine.2021.09.040. Epub 2021 Sep 27.
7
Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20-22 April 2021.会议报告：2021 年 4 月 20 日至 22 日虚拟全球结核病疫苗论坛。
Vaccine. 2021 Dec 8;39(50):7223-7229. doi: 10.1016/j.vaccine.2021.08.094. Epub 2021 Sep 15.
8
Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Quebec, Canada.BCG 对 SARS-CoV-2 感染提供长期保护吗？加拿大魁北克的一项病例对照研究。
Vaccine. 2021 Dec 8;39(50):7300-7307. doi: 10.1016/j.vaccine.2021.08.019. Epub 2021 Aug 11.
9
ESX-5-targeted export of ESAT-6 in BCG combines enhanced immunogenicity & efficacy against murine tuberculosis with low virulence and reduced persistence.卡介苗中靶向ESX-5的ESAT-6分泌兼具增强的免疫原性和抗小鼠结核病功效，且毒力低、持续性降低。
Vaccine. 2021 Dec 8;39(50):7265-7276. doi: 10.1016/j.vaccine.2021.08.030. Epub 2021 Aug 19.
10
BCG for the prevention and treatment of allergic asthma.卡介苗用于预防和治疗过敏性哮喘。
Vaccine. 2021 Dec 8;39(50):7341-7352. doi: 10.1016/j.vaccine.2021.07.092. Epub 2021 Aug 18.